Battle against psoriasis itch: which drug works better?
NCT ID NCT07432386
Summary
This study compares two existing medications—methotrexate and apremilast—to see which works better at reducing the severe itching that often accompanies psoriasis. Eighty adults with psoriasis and bothersome itching will take one of the two drugs for eight weeks. Researchers will measure how much the treatment improves their quality of life and reduces their itch.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pak Emirates Military Hospital
Rawalpindi, Punjab Province, 46000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.